Search

Your search keyword '"WAGNON J"' showing total 50 results

Search Constraints

Start Over You searched for: Author "WAGNON J" Remove constraint Author: "WAGNON J"
50 results on '"WAGNON J"'

Search Results

7. Chapter 15 Nonpeptide vasopressin receptor antagonists: development of selective and orally active V1a, V2 and V1b receptor ligands

10. Review of respiratory impact in oesophageal atresia

14. The Discovery of Novel Vasopressin V1b Receptor Ligands for Pharmacological, Functional and Structural Investigations.

25. Retrospective French nationwide survey of childhood aggressive vascular anomalies of bone, 1988-2009

27. Seizures Cause Prolonged Impairment of Ventilation, CO 2 Chemoreception and Thermoregulation.

28. The Importance of Monitoring the Postpartum Period in Moderate to Severe Crohn's Disease.

29. Risk Factors for Medication Nonadherence to Self-Injectable Biologic Therapy in Adult Patients With Inflammatory Bowel Disease.

30. A Single Center Experience With Long-Term Ustekinumab Use and Reinduction in Patients With Refractory Crohn Disease.

31. Use of Endoscopic Ultrasound to Guide Adalimumab Treatment in Perianal Crohn's Disease Results in Faster Fistula Healing.

32. Retrospective French nationwide survey of childhood aggressive vascular anomalies of bone, 1988-2009.

33. Biological characterization of rodent and human vasopressin V1b receptors using SSR-149415, a nonpeptide V1b receptor ligand.

34. [Breastfeeding and vegan diet].

35. An overview of SSR149415, a selective nonpeptide vasopressin V(1b) receptor antagonist for the treatment of stress-related disorders.

36. Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders.

37. Characterization of (2S,4R)-1-[5-chloro-1-[(2,4-dimethoxyphenyl)sulfonyl]-3-(2-methoxy-phenyl)-2-oxo-2,3-dihydro-1H-indol-3-yl]-4-hydroxy-N,N-dimethyl-2-pyrrolidine carboxamide (SSR149415), a selective and orally active vasopressin V1b receptor antagonist.

38. Nonpeptide vasopressin receptor antagonists: development of selective and orally active V1a, V2 and V1b receptor ligands.

39. [The treatment of static metatarsalgia using osteotomy of the base of the metatarsus, and its potential association with the Hohmann technique for treatment of hallux valgus].

41. [Leg fractures: choice of treatment according to type of fracture].

42. Conformational preferences and self-association modes of two diastereomeric statine derivatives.

43. Renin inhibitors. Free-Wilson and correlation analysis of the inhibitory potency of a series of pepstatin analogues on plasma renin.

44. Effects of a renin inhibitor, SR 43845, and of captopril on blood pressure and plasma active renin in conscious sodium-replete macaca.

46. [Personal experience with intermediate prostheses. Apropos of 276 cases].

47. [Colonothoracic fistulas: presentation of 2 cases].

Catalog

Books, media, physical & digital resources